Solex Resources Announces Granting of Options

September 28, 2009 � Vancouver B.C.: Solex Resources Corp. (TSX-V: SOX) (�Solex� or the �Company�) today announced that the board of directors of the Company has granted stock options to purchase an aggregate of 500,000 common shares of the Company at an exercise price of $0.125 C per share to Jonathan Challis, President and CEO of the Company. The grant of such stock options is made pursuant to the stock option plan of the Company. The granted options will expire on September 25, 2014.

About Solex Resources Corp.

Solex Resources Corp. is the dominant landholder in southern Peru's Macusani Uranium District with concessions covering over 904 km2 where in excess of 55 uraniferous anomalies have been identified on Solex properties. Solex is exploring three properties in the Macusani region (Macusani East, Macusani West and Macusani South), in addition to the Picotani uranium project.  NI 43-101 reports were filed during 2008 on the Princesa silver, lead and zinc property and on the Pilunani lead and zinc project.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain forward-looking statements that are based on Solex's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

-30-

FURTHER INFORMATION: